Cardiovascular Risk: Perspective

• Apr 11 2025 This Week in Cardiology  
  theheart.org on Medscape, April 11, 2025
• Beyond BMI: Weight Loss Produces More Health Benefits   Dr Sarah Barenbaum discusses realistic weight-loss goals.
  Medscape, April 11, 2025
• For America First, Invest in Science and the NIH   Panel discussion of a Presidential Advisory from the American Heart Association that outlines the importance of funding for scientific research and the need for a robust National Institutes of Health.
  theheart.org on Medscape, April 10, 2025
• Low T, Big Impact: Tips for Diagnosing Hypogonadism   On this segment of The Curbsiders, Dr Matthew Frank Watto and Dr Paul Nelson Williams discuss hypogonadism: who to test, what labs to run, and how to treat.
  The Curbsiders, April 10, 2025
• Cardiac Dysfunction Surfaces Early With Cancer Treatment Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.
  Medscape Medical News, April 10, 2025
• Can Europe Fill the Gap in Global Research Left by US Cuts? In this interview, Gilles Montalescot, MD, PhD, discusses the significant impact of US funding cuts on global medical research and the potential for Europe to step in.
  Medscape, April 09, 2025
• Effect of BMI on Cardiovascular Risk in RA Varies In patients with RA, BMI affects cardiovascular risk, differing by anti–citrullinated protein antibody (ACPA) status and biologic use.
  Medscape Medical News, April 09, 2025
• Hypertensive Pregnancy Increases Dilated Cardiomyopathy Risk Hypertensive disorders of pregnancy in first pregnancies double the risk for dilated cardiomyopathy, with the onset earlier than that in normotensive pregnancies.
  Medscape News UK, April 08, 2025
• GLP-1 Drugs Might Cut Dementia Risk in Half   New evidence brings more good news about the unanticipated effects of the GLP-1 receptor agonists.
  Medscape, April 07, 2025
• Apr 04 2025 This Week in Cardiology   Trials from the 2025 American College of Cardiology scientific sessions, including the WARRIOR, PROTECT TAVI, DAPATAVI, and SOUL are reviewed by John Mandrola, MD
  theheart.org on Medscape, April 04, 2025
• ACC 2025 Keep Fighting INOCA After Neutral WARRIOR Trial   Drs O’Donoghue, Handberg, and Bairey-Merz discuss the WARRIOR trial of intensive medical therapy in women with nonobstructive symptomatic CAD, presented at the ACC 2025 Scientific Session.
  theheart.org on Medscape, April 04, 2025
• Menopausal Hormone Therapy Isn't as Scary as You Think   Menopausal hormone therapy has been associated with increased risks for breast cancer, heart disease, and stroke — but are the risks worth the benefits? Dr Christopher Labos thinks so.
  Medscape Internal Medicine, April 03, 2025
• Early Statin Use Shows Sustained Cardiovascular Benefits Early introduction of atorvastatin in patients with hypertension demonstrates sustained cardiovascular benefits, a 20-year follow-up study reveals.
  Medscape News UK, April 01, 2025
• AAD 2025 HS Highlights From the AAD 2025 Annual Meeting   Hidradenitis suppurativa (HS) highlights from AAD 2025 include studies of HS patients' risk for cardiovascular disease or emergency department visits, and takeaways on optimizing use of HS therapies.
  Medscape, March 31, 2025
• Fatty Liver Disease Nearly Doubles Mortality Risk Patients with MASLD had nearly twice the all-cause mortality rate as the general population, suggesting the need for multidisciplinary care to reduce excess mortality, researchers said.
  Medscape Medical News, March 31, 2025
• Mar 28 2025 This Week in Cardiology   Stopping oral anticoagulation after AF ablation, the core problem with paradoxes like the smoker’s paradox, chronic total occlusion PCI, and an ACC/EHRA preview are discussed by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, March 28, 2025
• Which Diabetes Type Has Higher Stroke Risk? Type 1 diabetes increases the risk for both ischaemic and haemorrhagic stroke, whereas type 2 diabetes increases the risk for only ischaemic stroke, a study shows.
  Medscape News UK, March 26, 2025
• ACC 2025 BP Below 130 mm Hg Linked to CV Benefit in Octogenarians A systolic BP level below 130 mm Hg is associated with a lower risk for cardiovascular mortality than 130-160 mm Hg in adults older than 80 years taking antihypertensive medications.
  Medscape Medical News, March 26, 2025
• ACC 2025 Read clinically focused news coverage of key developments from ACC 2025
  theheart.org on Medscape, March 25, 2025
• ACC 2025 Mandrola’s 5 Picks for ACC 25 Trials on cerebral protection in TAVR, fluid restriction in heart failure, and risk factor management in AF are among John Mandrola’s picks from the upcoming ACC Scientific Sessions.
  theheart.org on Medscape, March 25, 2025